Keith RL - Search Results

1

High prevalence of endobronchial malignancy in high-risk patients with moderate dysplasia in sputum.

Kennedy TC, Franklin WA, Prindiville SA, Cook R, Dempsey EC, Keith RL, Hirsch FR, Merrick TA, Shroyer KR, Petty TL, Byers T, Bunn PA Jr, Miller YE. Kennedy TC, et al. Among authors: keith rl. Chest. 2004 May;125(5 Suppl):109S. Chest. 2004. PMID: 15136448 No abstract available.

2

Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer.

Keith RL, Miller YE, Gemmill RM, Drabkin HA, Dempsey EC, Kennedy TC, Prindiville S, Franklin WA. Keith RL, et al. Clin Cancer Res. 2000 May;6(5):1616-25. Clin Cancer Res. 2000. PMID: 10815878

3

Experimental evidence from an animal model of adenocarcinoma that chronic inflammation enhances lung cancer risk.

Malkinson AM, Bauer A, Meyer A, Dwyer-Nield L, Koski K, Keith R, Geraci M, Miller Y. Malkinson AM, et al. Chest. 2000 May;117(5 Suppl 1):228S. doi: 10.1378/chest.117.5_suppl_1.228s. Chest. 2000. PMID: 10843922 No abstract available.

4

Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer.

Keith RL, Miller YE, Hoshikawa Y, Moore MD, Gesell TL, Gao B, Malkinson AM, Golpon HA, Nemenoff RA, Geraci MW. Keith RL, et al. Cancer Res. 2002 Feb 1;62(3):734-40. Cancer Res. 2002. PMID: 11830527

5

Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results.

Garg K, Keith RL, Byers T, Kelly K, Kerzner AL, Lynch DA, Miller YE. Garg K, et al. Among authors: keith rl. Radiology. 2002 Nov;225(2):506-10. doi: 10.1148/radiol.2252011851. Radiology. 2002. PMID: 12409588 Clinical Trial.

6

Mycobacterium tuberculosis presenting as an infected pulmonary bulla.

Bull TM, Keith RL, Kraft M, Dempsy EC, Miller YE. Bull TM, et al. Among authors: keith rl. Int J Tuberc Lung Dis. 2003 May;7(5):504. Int J Tuberc Lung Dis. 2003. PMID: 12757057 No abstract available.

7

Induction of a high incidence of lung tumors in C57BL/6 mice with multiple ethyl carbamate injections.

Miller YE, Dwyer-Nield LD, Keith RL, Le M, Franklin WA, Malkinson AM. Miller YE, et al. Among authors: keith rl. Cancer Lett. 2003 Aug 20;198(2):139-44. doi: 10.1016/s0304-3835(03)00309-4. Cancer Lett. 2003. PMID: 12957351

8

The future of cyclooxygenase-2 inhibitors and other inhibitors of the eicosanoid signal pathway in the prevention and therapy of lung cancer.

Bunn PA Jr, Keith RL. Bunn PA Jr, et al. Among authors: keith rl. Clin Lung Cancer. 2002 May;3(4):271-7; discussion 278. doi: 10.3816/clc.2002.n.012. Clin Lung Cancer. 2002. PMID: 14662036

9

Prostacyclin in human non-small cell lung cancers.

Nana-Sinkam P, Golpon H, Keith RL, Oyer RJ, Sotto-Santiago S, Moore MD, Franklin W, Nemenoff RA, Geraci MW. Nana-Sinkam P, et al. Among authors: keith rl. Chest. 2004 May;125(5 Suppl):141S. doi: 10.1378/chest.125.5_suppl.141s. Chest. 2004. PMID: 15136467 No abstract available.

10

Pulmonary prostacyclin synthase overexpression chemoprevents tobacco smoke lung carcinogenesis in mice.

Keith RL, Miller YE, Hudish TM, Girod CE, Sotto-Santiago S, Franklin WA, Nemenoff RA, March TH, Nana-Sinkam SP, Geraci MW. Keith RL, et al. Cancer Res. 2004 Aug 15;64(16):5897-904. doi: 10.1158/0008-5472.CAN-04-1070. Cancer Res. 2004. PMID: 15313935

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters